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Abstract
Allergens are initiators of both innate and adaptive immune responses. They are recognised at the site of entry by epithelial
and dendritic cells (DCs), both of which activate innate inflammatory circuits that can collectively induce Th2 immune
responses. In an attempt to have a better understanding of the role of carbohydrates in the recognition and uptake of
allergens by the innate immune system, we defined common glycosylation patterns in major allergens. This was done using
labelled lectins and showed that allergens like Der p 1 (Dermatophagoides pteronyssinus group 1), Fel d 1 (Felis domisticus),
Ara h 1 (Arachis hypogaea), Der p 2 (Dermatophagoides pteronyssinus group 2), Bla g 2 (Blattella germanica) and Can f 1
(Canis familiaris) are glycosylated and that the main dominant sugars on these allergens are 1–2, 1–3 and 1–6 mannose.
These observations are in line with recent reports implicating the mannose receptor (MR) in allergen recognition and uptake
by DCs and suggesting a major link between glycosylation and allergen recognition. We then looked at TSLP (Thymic
Stromal Lymphopoietin) cytokine secretion by lung epithelia upon encountering natural Der p 1 allergen. TSLP is suggested
to drive DC maturation in support of allergic hypersensitivity reactions. Our data showed an increase in TSLP secretion by
lung epithelia upon stimulation with natural Der p 1 which was carbohydrate dependent. The deglycosylated preparation of
Der p 1 exhibited minimal uptake by DCs compared to the natural and hyperglycosylated recombinant counterparts, with
the latter being taken up more readily than the other preparations. Collectively, our data indicate that carbohydrate
moieties on allergens play a vital role in their recognition by innate immune cells, implicating them in downstream
deleterious Th2 cell activation and IgE production.
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Introduction
Allergens are foreign proteins that induce type I hypersensitivity
reactions through eliciting Th2 immune responses, which
culminate in IgE production and allergy. Epithelial cells are the
first line of defence against foreign antigens; they recognise
antigens through PRRs like TLRs [1,2] and through PAR 1-PAR
4 [3,4]. Ligation of these receptors with microbial motifs or
allergens activates innate immune responses, inflammatory
signalling pathways and the production of cytokines that direct
the Th1/Th2 immune polarization [3,4]. One key cytokine
secreted by epithelial cells in response to allergen exposure is
TSLP, an IL-7 like cytokine with a plethora of biological activities
[5]. It has recently been shown that high levels of TSLP induce
Th2 immune responses in humans by modulating the phenotype
of DCs (e.g. up-regulating the expression of OX40L) and by
directly acting on activated T cells [6–8]. Furthermore, upon
TSLP stimulation, DCs were found to produce the Th2 attracting
chemokines CCL17 and CCL22 [9,10] that have been shown to
recruit Th2 cells into the airway [10–12].
Whilst antigen-epithelial cell interaction leads to conditioning of
DCs with knock-on effects on downstream events such as T cell
differentiation, DCs act as sentinels of the immune system and are
able to recognise antigens at the site of entry through different
PRRs such as TLRs, NOD like receptors and C-type lectin
receptors [3]. They then present antigens to naive T helper cells in
draining lymph nodes leading to T cell differentiation into
functionally distinct subsets such as Th1, Th2, Treg and Th17
[3,12,13]. Amongst the well-studied PRR expressed by DCs are C-
type lectins, such as MR, DC-SIGN, dectin-1, langerin and DEC-
205 that are involved in the recognition and capture of many
glycosylated antigens as well as self-antigens and pathogens [14].
For example, MR recognises a wide range of both endogenous and
exogenous ligands through their carbohydrate moieties [15–17],
like mannose, fucose and N-acetylglucosamine [18,19].
It has been suggested that what might differentiate allergens
from other non-allergenic proteins lies in their protease activity,
surface features and/or glycosylation patterns. These three
features either singly or collectively might render some proteins
allergenic [20–22]. The contributions of protease activity and
surface features of allergens to allergenicity have been thoroughly
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33929investigated in recent years [20,23,24]. The glycosylation pattern
of allergens, however, has only recently been considered as a
possible distinguishing feature of these proteins. Much of the
research in this area has so far only focussed on the quantitative
determination of the carbohydrate content of allergens, without
much consideration for the whole carbohydrate structure and the
pattern of glycosylation or its biological relevance [25–27]. It is
known that carbohydrate determinants are the most frequently
encountered epitope structures for IgE [26,28], and as such have
been named Cross-reactive Carbohydrate Determinants (CCD).
These determinants are asparagine linked carbohydrate moieties
and they mainly consist of xylose and core-3-linked fucose, which
form the vital part of two independent IgE epitopes [28,29]. These
CCDs are mainly found in plants, insects and parasites, but are
absent in mammals and are therefore immunogenic [26,27].
In an attempt to have a better understanding of the role of
carbohydrates in allergen recognition by the innate immune
system, we examined a number of commonly encountered
allergens for their quantitative and qualitative carbohydrate
content by using labelled lectins known to react with specific
sugar moieties [15]. Having mapped the carbohydrate content of
these allergens, we then proceeded to define the influence of these
sugar residues on allergen recognition by epithelial cells and DCs.
The results obtained underline the pivotal role of carbohydrates in
allergen recognition and handling by innate immune cells, and this
should now pave the way for instigating novel approaches for
controlling allergic sensitizations at the point of initial contact with
the immune system.
Materials and Methods
Allergen and non allergen protein preparations
Purified natural and recombinant Der p 1, Der p 2, Fel d 1,
deglycosylated Fel d 1 (DFel d 1 lacking a major glycosylation site),
Can f 1, Ara h 1 and Bla g 2 were purchased from Indoor
Biotechnology, Warminster, UK. Papain, Bromelain and Calpain
ll were purchased from Sigma. The Staphopain B (StpB) was
purchased from Biocentrum Ltd, UK. Cysteine protease B (CPB)
was kindly provided by Prof Jeremy Mottram, University of
Glasgow (UK).
Glycosylation analysis
All protein preparations (5 mg per sample) were run on a 12%
Novex Tris-Glycine precast gel (Invitrogen, Paisley, UK) prior to
being transferred to nitrocellulose membrane following standard
procedure. This was followed by detection of different glycans
using DIG Glycan Differentiation Kit (Roche, Welwyn Garden
City, UK) following the manufacturer’s instructions (Table 1).
The detection of 1,3 fucose was done using anti-1,3 fucose
rabbit polyclonal antibody (no. AS07 268, Agrisera, UK) which
cross-reacts with fucose residues bound to N-Glycans in alpha 1,3
in plants and insects. The concentration of antibody used was
1 mg/10 ml of TBS buffer.
Periodate deglycosylation
Der p 1 preparations were treated with sodium metaperiodate
(Sigma) at a molar ratio of 5:1. The reaction mixture was
incubated for 30 and 60 mins at room temperature in the dark.
The oxidation process was stopped by adding 0.25 ml ethylene
glycol per ml of sample. Samples were then dialyzed at room
temperature overnight against PBS. The allergen preparations
were then labelled with Lightning-Link FITC Antibody Labelling
Kit from Novus Biologicals (Cambridge, UK).
Coomassie staining analysis
Gels were washed with deionised H2O and stained with
Coomassie brilliant blue Imperial ready to go stain (Invitrogen)
for 1 hr. They were then destained overnight with H2O according
to the manufacturer’s protocol.
Culturing BEAS-2B epithelial cells with different Der p 1
glycoforms
Human bronchial epithelial cell line BEAS-2B (kindly provided
by Professor Ian Hall, University of Nottingham, UK) was used for
measuring TSLP production in response to different allergen
preparations. Cells were cultured in Dulbecco’s Modified Eagle’s
Medium (Invitrogen), along with 10% low endotoxin foetal bovine
serum (Autogen Bioclear, UK), 2 mM L-Glutamine (Sigma) and
1% Penicillin/Streptomycin (Sigma). After reaching confluency,
the cells were then trypsinised using 0.25% trypsin-EDTA (Sigma)
and incubated for 5 minutes at 37uC, 5% CO2. BEAS-2B cells
(1610
6 cells/ml) were added to 24-well plates (Corning), together
with either 1 mg/ml of natural Der p 1 (Indoor Biotechnology) or
periodate deglycosylated natural Der p 1 (1 mg/ml). All cultures
received 50 ng/ml LPS (sigma). Plates were then incubated at
37uC, 5% CO2 for 24 hours. At the end of incubation,
supernatants were carefully collected from wells and transferred
to sterile 1.5 ml Eppendorf tubes (Axygen) then frozen at 220uC.
TSLP ELISA
Levels of human TSLP (hTSLP) in epithelial cell culture
supernatants were measured with a Human TSLP ELISA
development kit (Biolegand, UK) according to manufacturer’s
instructions.
Generation of dendritic cells
Dendritic cells were generated from peripheral blood-mono-
cytes as described before [30]. Briefly, human peripheral blood
mononuclear cells (PBMC) (obtained after informed consent and




mannose) DSA MMA PNA SNA
Anti-1,3
Fucose
nFel d 1 + + +++ 2 2 2
DFel d 1 2 2 + ++ 2 2
Der p 2 2 + ++ +++ ++ +
Ara h 1 +++ 2 + ++ ++ ++
Bla g 2 +++ ++ + ++ ++ +++
Can f 1 + 2 + 2 ++ 2
rDer p 1 +++ 2 2 + 2 2
Der p 1 + ++ 2 ++ ++ +++
Papain ++ + 2 + + ++
Bromelain + + 2 ++ + +++
+++: strong reaction, ++: moderate reaction, +: mild reaction, 2: no reaction.
Sugar binding specificities of lectin used for glycosylation analysis are as
follows: GNA recognises terminal mannose (1–3), (1–2) and (1–6) linked to
Mannose; DSA, recognises galactose (1–4) linked to N-acetylgalactosamine;
MAA recognises sialic acid linked (2–3) to galactose; PNA recognises core
galactose (1–3) N acetylgalactosamine; SNA, recognises sialic acid linked (2–6)
to galactose; Anti 1, 3 Fucose recognises core (1,3) fucose. DSA, Datura
stramonium agglutinin; GNA, Galanthus nivalis agglutinin; MAA, Maackia
amurensis agglutinin; PNA, peanut agglutinin; SNA, Sambucus nigra agglutinin.
doi:10.1371/journal.pone.0033929.t001
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density gradient centrifugation on Histopaque (HISTOPAQUE-
1077, Sigma, Irvine, UK). Purified PBMCs were incubated with
mouse anti-human CD14
+ monoclonal antibody conjugated to
magnetic beads (Miltenyi Biotec, Surrey, UK). Cells were then
washed and applied onto a column placed in the magnetic field of
a MACS separator (Miltenyi Biotec, Surrey, UK). CD14+ cells
(monocytes) were cultured (1610
6 cells per ml) in 48-well flat-
bottomed culture plates (Costar, High Wycombe, UK) in RPMI-
1640 medium supplemented with L-glutamine, antibiotics (Sigma,
Irvine, UK) and 10% fetal calf serum (FCS, Harlan Sera-Lab,
Loughborough, UK) containing 50 ng/ml of granulocyte-macro-
phage colony stimulating factor (GM-CSF) and 250 U/ml of IL-4
[DC-medium] (R&D Systems, Oxford, UK) at 37uCi n5 %C O 2
for 6 days.
Allergen/non-allergen uptake and inhibition assays
DCs were washed and re-suspended in uptake medium
consisting of 70% RPMI (RPMI 1640, Sigma, Irvine, UK), 25%
PBS (Sigma, Irvine, UK) with Ca
2+ and Mg
2+ and 5% FCS (FCS,
Harlan Sera-Lab, Loughborough, UK). Natural Der p 1 (nDer p
1) preparations were labelled with Cy5 (GE healthcare, Bedford,
UK) in some experiments and FITC in others (Novus Bio,
Cambridge, UK), recombinant Der p 1 (rDer p 1) and Staphopain
B were labelled with FITC. In the uptake assays, cells were pre-
incubated with natural or recombinant Der p 1 preparations (0.5
to 20 mg/ml) and their deglycosylated counterparts or Staphopain
B (1.0 mg/ml), which is not an allergen. In the inhibition assays,
mannan (200 mg/ml), galactose-PAA (200 mg/ml) and rDer p 1
(0.5 to 20 mg/ml) were incubated with the DCs for 20 mins at
37uC before the addition of Der p 1 followed by incubation for
another 25 mins at 37uC. The uptake of labelled natural and
recombinant Der p 1 was then immediately determined by flow
cytometry using a Beckman–Coulter Altra flowcytometer (Beck-
man-Coulter, High Wycombe, UK) and expressed as mean
fluorescence intensity (MFI). At least 10,000 cells per sample were
analysed.
Confocal imaging
Day 6 immature DCs were collected and washed with warm
RPMI. Natural and recombinant (Indoor Biotechnology) Der p 1
preparations were labelled with FITC (Novus Bio, Cambridege,
UK) and Cy5 (GE Healtcare, Bedford, UK), respectively. The
cells were then incubated at RT for 5, 10, 15 or 30 mins with
labelled allergens (1.0 mg/ml) prior to fixation with 4% formalde-
hyde and permeabilised with 0.1% triton X. The following
antibodies and labelling reagents were used for cell staining: anti-
MR (CD206) (PE; Clone 3.29B1.10, Coulter Immunotech), anti-
LAMP-2(Lysosomal-associated membrane protein 2) PE (Clone
GL2A7, Bioquote) and Fluoro-Trap Fluorescein Labelling Kit
[FITC] were used according to manufacturer’s protocol (Novus-
bio, UK). This reaction was incubated for 30 mins at RT. To label
the nucleus, DAPI stain (Thermo Scientific) was used. For
imaging, samples were set up on poly-l-lysine coated slides,
covered with cover slips and imaged by LSM 510 meta Confocal
Laser Scanning Microscopes (Carl Zeiss International) at 406and
606. Negative controls (cells labelled with the fluorochromes only
(PE, Cy5, FITC)) were used to set up the lasers for imaging. Co-
localization and image analysis were done using the LSM 510
image browser program.
Anti-Der p 1 5H8 ELISA
Different unlabelled Der p 1 allergen preparations (natural and
deglycosylated) were used at concentration of 2 mg/ml. Maxisorb
ELISA Plates (Nunc, Roskilde, Denmark) were coated overnight
by the allergen preparations, blocked with TBS buffer (TBS, 1%
BSA), washed, then 5H8 anti-Der p 1 biotinylated antibody (clone
5H8 C12 D8) Indoors Biotechnology, Warminster, UK) was
added and incubated at 2 mg/ml for 2 hours at room temperature.
The binding was then detected by incubation with Extra-avidin
alkaline phosphatase conjugate diluted 1:1000 in TBS buffer
(Sigma-Aldrich, Irvine, UK). Afterwards, plates were developed
with 100 ml/well of (1 mg/ml) pNPP (Sigma-Aldrich, Irvine, UK).
Absorbance was measured at 405 nm on a plate reader (Multiskan
Ex, Labsystems, Helsinki, Finland). All assays were carried out in
triplicate.
MR binding
All washes and incubations were carried out in lectin buffer
consisting of 10 mM Tris-HCl, pH 7.5, 10 mM Ca
2+, 0.154 M
NaCl and 0.05% (w/v) Tween 20. Different Der p 1 glycoforms at
concentration of 2 mg/ml Der p 1 (Indoor Biotechnology), as well
as 2 mg/ml of the corresponding carbohydrate ligand [Mannan
(Sigma-Aldrich, Irvine, UK) or Galactose (Gal-PAA) (Lectinity,
Moscow, Russia)] were used to coat the wells of Maxisorb ELISA
plates (Nunc, Roskilde, Denmark) by overnight incubation in PBS
Figure 1. Comparative analysis of cysteine protease allergens and non-allergens in terms of mannosylation. Allergens are strongly
mannosylated and have stronger reaction with anti-mannose GNA compared to non-allergens. +++: strong reaction, ++: moderate reaction, +: mild
reaction, 2: no reaction.
doi:10.1371/journal.pone.0033929.g001
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Dr Luisa Martinez-Pomares, University of Nottingham, UK) was
then added at 2 mg/ml and incubated for 2 hours at room
temperature. The binding was detected by incubation with anti-
human IgG gamma-chain-specific alkaline phosphatase conjugate
diluted 1:1000 in the lectin buffer. Afterwards, plates were
developed with 100 ml/well of (1 mg/ml) pNPP (Sigma-Aldrich,
Irvine, UK) as a phosphatase chromogenic substrate. Absorbance
was measured at 405 nm on a plate reader (Multiskan Ex,
Labsystems, Helsinki, Finland). All assays were carried out in
triplicate.
Statistical analysis
Statistical analysis of the data was carried out using Student’s t-
test and P-values,0.05 were considered significant. Flow cytometry
data were expressed as MFI 6 SEM; number of independent
experiments $3.
Results
Detecting the pattern of N- and O-glycosylation in
allergens
Using GNA, SNA, PNA, MMA and DSA labelled lectins and
anti-1,3 fucose antibody, allergens were assessed for the presence
Figure 2. MFI ± SEM readings which represent the difference in uptake between natural and recombinant Der p 1 (1 mg/ml) by
immature DCs. There was a significant difference between natural and recombinant allergen uptake. The results suggest that the average mean of
uptake for the recombinant preparation is higher than that for natural Der p 1. The results also show that the uptake of Der p 1 by immature DCs at
4uC is lower than the uptake at 37uC for both preparations. Both natural and recombinant Der p 1 were labelled with FITC. *P value,0.05.
doi:10.1371/journal.pone.0033929.g002
Figure 3. Confocal images of the difference between recombinant and natural Der p 1 (0.5 mg/ml) uptake by the same immature DC
at 376C. The results suggest that the uptake of the recombinant preparation (A) is higher than that for natural Der p 1 (B) in the same DC. A. Green:
rDer p 1 labelled with FITC, red: MR labelled with PE, blue: nucleus labelled with DAPI. B. Green: nDer p 1 labelled with Cy5, red: MR labelled with PE,
blue: nucleus labelled with DAPI.
doi:10.1371/journal.pone.0033929.g003
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from Dermatophagoides pteronyssinus, reacted with GNA which
recognises 1–2,3 and 1–6 mannose, suggesting that it has high
mannose N-glycans in its natural form [15]. Der p 1 also showed a
positive reaction with anti-1,3 fucose (Table 1), which indicates
that it has part of the CCD 1,3 fucose on its N-glycosylation site
which is linked to asparagine. It also reacted with DSA, PNA and
SNA, which respectively recognise 1,4 galactose, 1,3 galactose and
sialic acid linked 2–6 to galactose. Der p 1 failed to react with
MMA, thus suggesting that it does not contain any sialic acid
binding to 2–3 galactose.
The recombinant preparation of Der p 1 that is produced in
Pichia pastoris reacted with GNA to a higher degree than the
natural preparation. The band itself was diffused, suggesting
hyperglycosylation and its positive reaction with GNA confirmed
that most of the glycosylation is due to mannosylation which is
expected as proteins expressed in yeast tend to be hypermanno-
sylated [24,31–34]. The preparation also reacted with PNA
suggesting that it also has some 1,3 galactose.
Unlike natural Der p 1, the recombinant preparation does not
have any sialic acid or 1,4 galactose.
Fel d 1, the major cat allergen Felis domesticus, is shown here to
have low levels of mannan as well as showing strong reactions with
DSA and MAA, thus suggesting that it has 1,4 galctose and sialic
acid (Table 1). It does not, however, contain 1,3 fucose which is
expected as 1,3 fucose is not present in mammals. The
recombinant deglycosylated counterpart of Fel d 1 does not
contain any mannan, but it does contain sialic acid and 1,3
galactose (Table 1). Can f 1, the dog allergen Canis familiaris, is also
not fucosylated as it is from a mammalian source [34,35], but it is
mannosylated and appears to contain sialic acid too (Table 1). The
two allergens that showed a very strong reaction with mannan, in
addition to rDer p 1, were Ara h 1 (Arachis hypogaea) and Bla g 2
(Blattella germanica). These two allergens are highly mannosylated in
their natural forms (Table 1).
The other major house dust mite allergen, Der p 2, failed to give
a positive reaction with GNA, indicating the lack of mannan in
this allergen. It did, however, react with 1,3 fucose and also
reacted positively with DSA, MMA, PNA and SNA, which suggest
the presence of other carbohydrate moieties.
The mannosylation patterns of allergens and non-
allergens
Our data indicate that mannosylation appears to be a dominant
feature among allergens (Table 1). Therefore, a comparative
carbohydrate analysis was done for proteins that are not known to
Figure 4. A. Natural and recombinant Der p 1 uptake by immature DCs at 37uC compared to the non-allergen Staphopain B at the same conditions
and concentrations. Results presented as MFI 6 SDM and all preparations were labelled with FITC. B. Confocal images of the uptake of Staphopain B
by immature DCs.
doi:10.1371/journal.pone.0033929.g004
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Protease B (CPB) [36–38], yet share the same protein family with
allergens such as Papain, Bromelain and Der p 1 [39–41]. All
these proteins have potent cysteine protease activity, but very little
is known about their glycosylation pattern. Following experiments
using GNA lectin it became clear that the non-allergens
Staphopain B, Calpain and CPB do not react with GNA, thus
indicating that unlike allergens they are not mannosylated (Fig. 1).
Staphopain B also did not react with any of the other lectins,
indicating that it does not have any mannose, galactose or sialic
acid.
Comparative analysis of natural Der p 1, recombinant Der
p 1 and Staphopain B uptake by immature DCs
Both natural and recombinant (hyperglycosylated) Der p 1
preparations are glycosylated albeit to different degrees. Stapho-
Figure 5. The uptake of recombinant and natural preparations of Der p 1 (1 mg/ml) by immature DCs at 30 mins. A. Green: rDer p1
stained with FITC, red: MR stained with PE, blue: nucleus stained with DAPI. B. Green: nDer p 1 stained with Cy5, red: MR stained with PE, blue: nucleus
stained with DAPI.
doi:10.1371/journal.pone.0033929.g005
Figure 6. The co-localization of natural and recombinant Derp1
(0.5 mg/ml) with LAMP-2 detected at 10 mins. A. Green: rDer p 1
stained with FITC, red: LAMP-2 stained with PE, blue: nucleus stained
with DAPI. B. Green: nDer p 1 stained with Cy5, red: LAMP-2 stained
with PE, blue: nucleus stained with DAPI.
doi:10.1371/journal.pone.0033929.g006
Figure 7. Western blot against GNA (anti-mannose) of natural
and recombinant Der p 1 before and after periodate treatment.
The blot shows minimal reaction with GNA for both preparations after
periodate treatment, indicating that periodate removed most of the
mannan. The concentration of the protein loaded in each well was
2.0 mg/ml.
doi:10.1371/journal.pone.0033929.g007
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shown to be an amannosylated antigen. To investigate the effect of
glycosylation on the uptake of Der p 1 by DCs, we incubated all
preparations under the same conditions with immature DCs at
37uC. All preparations were labelled by FITC and thus the uptake
could be measured comparatively by flow cytometry as MFI
readings. The control conditions for these experiments were DCs
incubated with allergens at 4uC and DCs only. Levels of allergen
uptake for each condition is presented as MFI (Fig. 2) and is also
visualised using confocal imaging (Fig. 3). The results suggest that
the average mean of uptake for recombinant Der p 1
(hyperglycosylated) is significantly (*P value,0.05) higher than
that of natural Der p 1 at any given time point. We also studied the
uptake of Staphopain B antigen, which is not known to induce any
allergic reactions and is not mannosylated, and the results show
minimal uptake of this non-allergen compared to Der p 1 (Fig. 4A
& B).
The confocal images also showed the co-localization of both
Der p 1 preparations with MR (Fig. 5), although the co-
localization coeffecient was found to be higher for rDer p 1
(0.911 compared to 0.84 for nDer p 1). Recombinant and natural
Der p 1 also co-localised with the Lysosomal-associated membrane
protein 2 (LAMP-2), which shuttles between lysosomes, endosomes
and the plasma membrane (Fig. 6).
Sodium periodate deglycosylation of natural and
recombinant Der p 1
Periodate oxidation was used to deglycosylate both natural and
recombinant Der p 1 preparations by using sodium metaper-
iodate. Periodate has been used in the literature to deglycosylate
protein preparations [42–45] and it is known to remove mannose
and fucose from proteins. Natural and recombinant Der p 1 were
incubated with periodate in the dark at room temperature for 30
and 60 mins. A western blot against GNA (anti 1–2,3,6 mannose)
was performed on the samples before and after periodate
treatment (Fig. 7) to confirm that demannosylation had worked.
All these glycoforms retained their reactivity with anti-Der p 1
5H8 monoclonal antibody (Fig. 8), thereby ascertaining their
structural integrity. A commassie blue stained gel of natural Der p
1 before and after deglycosylation with periodate showed a slight
decrease in deglycosylated Der p 1 MW as to be expected (Fig. 9).
The preparations were then labelled with FITC and the uptake by
DCs was measured against untreated preparations (Fig. 10 A).
The results indicate a significant decrease in the uptake of both
Der p 1 preparations after periodate treatment. The periodate
treated recombinant preparation (1 mg/ml) showed a 53%
Figure 8. ELISA experiments showing the binding of natural Der p 1 and recombinant Der p 1 to anti-Der p 1 5H8 antibody before
and after deglycosylation with periodate. Der p 1 was used at the same concentration (2.0 mg/ml) for all conditions. Data show the average of
triplicate experiments.
doi:10.1371/journal.pone.0033929.g008
Figure 9. Commassie blue stained gel of natural Der p 1 before
and after deglycosylation with periodate showing a slight
decrease in the MW of deglycosylated Der p 1.
doi:10.1371/journal.pone.0033929.g009
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untreated preparation of the same concentration; at 60 mins of
periodate oxidation the uptake decreased to 81.6%. The periodate
treated natural sample showed a decrease of 58.7% after 30 mins
of treatment and 90% decrease in uptake after 60 mins (Fig. 10 A).
We also used confocal microscopy to detect the uptake of
periodate treated natural Der p 1. This showed almost complete
abrogation of Der p 1 uptake after 60 min periodate oxidation
(Fig. 10 B).
MR binding by the different glycoforms of Der p 1
In order to study the effect of glycosylation on Der p 1
recognition by MR, binding to MR subfragment CTLD 4–7, the
C-type lectin carbohydrate recognition domain which has been
shown to be the main Der p 1 binding site, was investigated using
ELISA. Mannan and galactose were used as positive and negative
controls, respectively. Results in Fig. 11 show a significant decrease
in binding to MR (.55%) when Der p 1 was deglycosylated with
periodate for 60 mins. The same effect was also seen with
hypermannosylated rDer p 1, as the decrease in binding after
deglycosylation reached 42.5%. It is clear that the binding of the
recombinant preparation of Der p 1 to MR is much stronger than
that of natural Der p 1, which is expected since rDer p 1 has more
mannan than its natural counterpart.
Differences in TSLP secretion induced by the different
glycoforms of Der p 1
Different glycoforms of Der p 1 were incubated with a human
epithelial cell line (BEAS-2B) for 24 hrs followed by TSLP
measurement in the supernatants. Results in Fig. 12 show a
significant increase in TSLP secretion by human epithelial cells
when challenged by Der p 1, with lower TSLP production in
response to deglycosylated Der p 1.
Discussion
Glycosylation in allergens is a key structural feature and
mannosylation seems to be the dominant glycosylation pattern
with the exception of Der p 2, which possesses galactose, sialic acid
and N-acetylglucosamine. We have shown the predominance of
mannan in some of the most dominant environmental allergens
such as Ara h 1, Bla g 1, Can f 1, Fel d 1, Bromelain and Papain.
We also showed that mannosylation is absent in non-allergen
proteins that are structurally similar to cysteine protease allergens.
Figure 10. A. The MFI 6 SEM readings for the uptake of different concentrations of nDer p 1 and rDer p 1 by immature DCs compared to the
periodate treated preparations. Both nDer p 1 and rDer p 1 were treated with periodate for 30 mins and 1 hr, then their uptake was measured. The
results show a significant decrease in uptake of periodate treated preparations compared with the untreated ones.*** P value,0.001, all Der p 1
preparations were labelled with FITC. B. Confocal images showing the uptake of periodate treated Der p 1 by immature DCs.
doi:10.1371/journal.pone.0033929.g010
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Cry j 1 [46], pollen allergen Cha o 1 [47], yellow jacket allergen
Ves v 2 [48] and Ovalbumin [49]. Ara h 1, Cor a 11, Jug r 2 and
Ana o 1 allergens have been reported to contain a xylose and
mannose in the N-glycan chain [50,51]. Fucose 1,3 is reported to
be present in a wide range of allergens like Hev b 1, Ara h 1,
Bromelain and Papain [29,35,52]. The degree of mannosylation
clearly differs between allergens like Der p 1, Papain, Bromelain
and their structurally similar non-allergen counterparts like CPB,
Calpain and Staphopain B.
The detection of galactose 1,3, galactose 1,4, sialic acid and 1,3
fucose in allergens provided for the first time a better insight into
the structure of carbohydrates in allergens. Although most reports
concentrate on N-glycosylation as a target for lectin receptors on
antigen presenting cells, some recent reports did suggest that O-
glycosylation by itself plays a role in CCD [53–55], which is why it
is important to be comprehensive in studying glycans on allergens
and determining the specific structures of both O- and N-glycans
in them.
The recombinant hypermannosylated Der p 1 preparation used
in this study was taken up more readily by DCs than natural Der p
1, and this underlines the importance of sugars in allergen
recognition by C-type lectin receptors like MR and DC-SIGN
[15,19,56,57]. We have previously shown that Der p 1 binding to
MR, most likely through regulation of indoleamine 2,3 dioxygen-
ase (IDO) activity, plays a key role in down stream allergen
induced Th2 cell differentiation [15]. Given the commonality of
mannosylation amongst allergens from diverse sources, it is
Figure 11. Binding of MR C-type lectin-like carbohydrate recognition domains 4–7 with different glycoforms of Der p 1, nDer p 1
and rDer p 1 (concentrations at 2 mg/ml). ***P value,0.001.
doi:10.1371/journal.pone.0033929.g011
Figure 12. Differences in TSLP secretion in human BEAS-2B epithelial cells after 24 hrs stimulation with different glycoforms of Der
p1 .Concentration of all Der p 1 preparations used was 1 mg/ml. ***P value,0.001.
doi:10.1371/journal.pone.0033929.g012
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role in their allergenicity. Within this context, it is therefore not
surprising that the non-allergen Staphopain B, which is not
mannosylated, is not taken up efficiently by immature DCs
compared to Der p 1.
The above data were further corroborated by demannosylating
Der p 1 via chemical deglycosylation resulting in a preparation
exhibiting minimal uptake by DCs. This was best exemplified by
sodium metaperiodate treatment of Der p 1. Sodium metaper-
iodate treatment does not affect the protein conformation under
mild conditions, and it was shown that at 10 mM will lead to
alterations in carbohydrates structure without any significant effect
on proteins integrity in Schistosoma mansoni Egg antigens [45].
Periodate was also used to destroy carbohydrates on Cry j 1, the
major allergen of Japanese cedar pollen, and it was shown that
after periodate oxidation Cry j 1-specific CD4+ T cell proliferation
decreased significantly and there was also significantly less IL-4
and IL-5 secretion in comparison with the control antigen [58].
Consequently, those authors suggested a role for carbohydrates in
Cry j 1 in promoting Th2 immune responses in vitro.
The confocal images provided an insight into the uptake of
different Der p 1 preparations by DCs. It became clear that the
internalization of Der p 1 is initiated by MR on immature DCs.
Despite, different rate of uptake by DCs, both recombinant and
natural Der p 1 co-localised with LAMP-2, a lysosomal marker,
suggesting a common fate for these preparations inside the DC.
Epithelial cells provide the initial barrier for defence against
allergens. The epithelial barrier in the skin, gastrointestinal tract
and airways plays an important role in initiating immune
responses by secreting chemokines, cytokines and growth factors
like IL-1, IL-6, IL- 8, GM-CSF, Interferon a and b, TNF-a and
others which provoke immune and inflammatory reactions
[5,10,59]. Epithelial cells also produce TSLP in response to
allergen exposure. This cytokine was originally described in B cell
proliferation and development [60]. Since then, TSLP has been
described to target and regulate numerous DC and monocyte
activities. Several studies concluded that TSLP drives DC
maturation for Th2 immune responses via enhancing pro-allergic
Th2 type cytokines like IL-4, IL-5 and IL-13 [6,10,61] and up-
regulating the co-stimulatory molecules CD40, CD80, CD83 and
CD86 [10,60–65].
House dust mite allergens have been shown to induce TSLP
production by epithelial cells [66,67]. This was confirmed by our
data showing a significant increase in the secretion of TSLP by
epithelial cells in response to Der p 1 compared to the non-
allergen controls. Interestingly, the level of TSLP production in
response to Der p 1 stimulation seems to be positively related to
the level of allergen glycosylation, since when challenging human
epithelial cells with a deglycosylated preparation of Der p 1, the
TSLP secretion was significantly reduced. This may therefore
indicate the presence of lectin like receptors on epithelial cells and
a role for carbohydrates in recognition of allergens by the
epithelia.
In conclusion, this work progresses the definition of allergenicity
and correlates it to the glycosylation pattern of allergens. Thus, it
appears that glycosylation is a key feature of many allergens and
that mannan seems to be the dominant sugar moiety associated
with allergens [15,68,69]. Therefore, it is now tempting to suggest
that the counter structures of these carbohydrates on innate
immune cells, namely MR and other C-type lectin receptors, could
potentially be targeted to stop allergen uptake at the point of initial
contact with innate body defences. Alternatively, developing
different glycoforms of allergens with ‘Immune-regulatory’ prop-
erties could prove to be a useful strategy in allergen-specific
immunotherapy approaches [70,71].
Acknowledgments
We are grateful to Dr Luisa Martinez-Pomares for providing the MR
CTLD 4–7 constructs.
Author Contributions
Conceived and designed the experiments: FS AMG. Performed the
experiments: AA ME IKS HH RKJ. Analyzed the data: AA FS AMG.
Contributed reagents/materials/analysis tools: AMG FS. Wrote the paper:
AA FS AMG.
References
1. Schaible B, Schaffer K, Taylor CT (2010) Hypoxia, innate immunity and
infection in the lung. Respiratory Physiology & Neurobiology 174: 235–243.
2. Kato A, Favoreto S, Avila PC, Schleimer RP (2007) TLR3- and Th2 Cytokine-
Dependent Production of Thymic Stromal Lymphopoietin in Human Airway
Epithelial Cells. The Journal of Immunology 179: 1080–1087.
3. Hammad H, Lambrecht BN (2008) Dendritic cells and epithelial cells: linking
innate and adaptive immunity in asthma. Nat Rev Immunol 8: 193–204.
4. Chaudhuri N, Sabroe I (2008) Basic science of the innate immune system and
the lung. Paediatric respiratory reviews 9: 236–242.
5. He R, Geha RS (2010) Thymic stromal lymphopoietin. Annals of the New York
Academy of Sciences 1183: 13–24.
6. Ito T, Wang Y-H, Duramad O, Hori T, Delespesse GJ, et al. (2005) TSLP-
activated dendritic cells induce an inflammatory T helper type 2 cell response
through OX40 ligand. The Journal of Experimental Medicine 202: 1213–1223.
7. Rochman I, Watanabe N, Arima K, Liu Y-J, Leonard WJ (2007) Cutting Edge:
Direct Action of Thymic Stromal Lymphopoietin on Activated Human CD4+ T
Cells. The Journal of Immunology 178: 6720–6724.
8. Reche PA, Soumelis V, Gorman DM, Clifford T, Liu M-r, et al. (2001) Human
Thymic Stromal Lymphopoietin Preferentially Stimulates Myeloid Cells. The
Journal of Immunology 167: 336–343.
9. Comeau MR, Ziegler SF (2009) The influence of TSLP on the allergic response.
Mucosal Immunol 3: 138–147.
10. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, et al. (2002) Human
epithelial cells trigger dendritic cell-mediated allergic inflammation by producing
TSLP. Nat Immunol 3: 673–680.
11. Zhou B, Comeau MR, Smedt TD, Liggitt HD, Dahl ME, et al. (2005) Thymic
stromal lymphopoietin as a key initiator of allergic airway inflammation in mice.
Nat Immunol 6: 1047–1053.
12. Ying S, OA ˆ’Connor B, Ratoff J, Meng Q, Mallett K, et al. (2005) Thymic
Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and
Correlates with Expression of Th2-Attracting Chemokines and Disease Severity.
The Journal of Immunology 174: 8183–8190.
13. Adams EW, Ratner DM, Seeberger PH, Hacohen N (2008) Carbohydrate-
Mediated Targeting of Antigen to Dendritic Cells Leads to Enhanced
Presentation of Antigen to T Cells. ChemBioChem 9: 294–303.
14. Erbacher A, Gieseke F, Handgretinger R, Mu ¨ller I (2009) Dendritic cells:
Functional aspects of glycosylation and lectins. Human Immunology 70:
308–312.
15. Royer P-J, Emara M, Yang C, Al-Ghouleh A, Tighe P, et al. (2010) The
Mannose Receptor Mediates the Uptake of Diverse Native Allergens by
Dendritic Cells and Determines Allergen-Induced T Cell Polarization through
Modulation of IDO Activity. J Immunol 185: 1522–1531.
16. Gazi U, Martinez-Pomares L (2009) Influence of the mannose receptor in host
immune responses. Immunobiology 214: 554–561.
17. Deslee Gt, Charbonnier A-S, Hammad H, Angyalosi G, Tillie-Leblond I, et al.
(2002) Involvement of the mannose receptor in the uptake of der p 1, a major
mite allergen, by human dendritic cells. Journal of Allergy and Clinical
Immunology 110: 763–770.
18. Kerrigan AM, Brown GD (2009) C-type lectins and phagocytosis. Immunobi-
ology 214: 562–575.
19. Taylor PR, Gordon S, Martinez-Pomares L (2005) The mannose receptor:
linking homeostasis and immunity through sugar recognition. Trends in
Immunology 26: 104–110.
20. Shakib F, Ghaemmaghami AM, Sewell HF (2008) The molecular basis of
allergenicity. Trends in Immunology 29: 633–642.
21. Furmonaviciene R, Sutton BJ, Glaser F, Laughton CA, Jones N, et al. (2005) An
attempt to define allergen-specific molecular surface features: a bioinformatic
approach. pp 4201–4204.
22. Huby RDJ, Dearman RJ, Kimber I Why Are Some Proteins Allergens?. pp
235–246.
Allergen Glycosylation and Allergenicity
PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e3392923. Wills-Karp M, Nathan A, Page K, Karp CL (2009) New insights into innate
immune mechanisms underlying allergenicity. Mucosal Immunol 3: 104–110.
24. Meno K, Thorsted PB, Ipsen H, Kristensen O, Larsen JN, et al. (2005) The
Crystal Structure of Recombinant proDer p 1, a Major House Dust Mite
Proteolytic Allergen. J Immunol 175: 3835–3845.
25. Poltl G, Ahrazem O, Paschinger K, Ibanez MD, Salcedo G, et al. (2007)
Molecular and immunological characterization of the glycosylated orange
allergen Cit s 1. pp 220–230.
26. Fo ¨tisch K, Vieths S (2001) N- and O-linked oligosaccharides of allergenic
glycoproteins. Glycoconjugate Journal 18: 373–390.
27. Altmann F (2007) The Role of Protein Glycosylation in Allergy. International
Archives of Allergy and Immunology 142: 99–115.
28. Chunsheng J, Brigitte H, Wolfgang H, Johannes S, Friedrich A (2008) Affinity of
IgE and IgG against cross-reactive carbohydrate determinants on plant and
insect glycoproteins. The Journal of allergy and clinical immunology 121:
185–190.e182.
29. van Ree R, Cabanes-Macheteau M, Akkerdaas J, Milazzo J-P, Loutelier-
Bourhis C, et al. (2000) Beta(1,2)-Xylose and alpha (1,3)-Fucose Residues Have a
Strong Contribution in IgE Binding to Plant Glycoallergens. pp 11451–11458.
30. Horlock C, Shakib F, Mahdavi J, Jones NS, Sewell HF, et al. (2007) Analysis of
proteomic profiles and functional properties of human peripheral blood myeloid
dendritic cells, monocyte-derived dendritic cells and the dendritic cell-like KG-1
cells reveals distinct characteristics. Genome Biology 8: R: 30.31–, R: 30.12.
31. Jacquet A, Magi M, Petry H, Bollen A (2002) High-level expression of
recombinant house dust mite allergen Der p 1 in Pichia pastoris. Clinical &
Experimental Allergy 32: 1048–1053.
32. Cereghino JL, Cregg JM (2000) Heterologous protein expression in the
methylotrophic yeast Pichia pastoris. FEMS Microbiology Reviews 24: 45–66.
33. van Oort E, de Heer PG, van Leeuwen WA, Derksen NIL, Muller M, et al.
(2002) Maturation of Pichia pastoris-derived recombinant pro-Der p 1 induced
by deglycosylation and by the natural cysteine protease Der p 1 from house dust
mite. European Journal of Biochemistry 269: 671–679.
34. Staudacher E, Altmann F, Wilson IBH, Ma ¨rz L (1999) Fucose in N-glycans:
from plant to man. Biochimica et Biophysica Acta (BBA) - General Subjects
1473: 216–236.
35. Altmann F (2007) The Role of Protein Glycosylation in Allergy. International
Archives of Allergy and Immunology 142: 99–115.
36. Lanfranco MF, Loayza-Muro R, Clark D, Nu ´n ˜ez R, Zavaleta AI, et al. (2008)
Expression and substrate specificity of a recombinant cysteine proteinase B of
Leishmania braziliensis. Molecular and Biochemical Parasitology 161: 91–100.
37. Smagur J, Guzik K, Bzowska M, Kuzak M, Zarebski M, et al. (2009)
Staphylococcal cysteine protease staphopain B (SspB) induces rapid engulfment
of human neutrophils and monocytes by macrophages. Biological Chemistry
390: 361–371.
38. Goll DE, Thompson VF, Li H, Wei WEI, Cong J The Calpain System. pp
731–801.
39. Ghaemmaghami AM, Gough L, Sewell HF, Shakib F (2002) The proteolytic
activity of the major dust mite allergen Der p 1 conditions dendritic cells to
produce less interleukin-12: allergen-induced Th2 bias determined at the
dendritic cell level. Clinical & Experimental Allergy 32: 1468–1475.
40. Bu ¨hling F, Fengler A, Brandt W, Welte T, Ansorge S, et al. (2002) Review:
Novel Cysteine Proteases of the Papain Family. Cellular Peptidases in Immune
Functions and Diseases 2. pp 241–254.
41. Ishihara H, Takahashi N, Oguri S, Tejima S (1979) Complete structure of the
carbohydrate moiety of stem bromelain. An application of the almond
glycopeptidase for structural studies of glycopeptides. Journal of Biological
Chemistry 254: 10715–10719.
42. Perlin AS (2006) Glycol-Cleavage Oxidation. In: Derek H, ed. Advances in
Carbohydrate Chemistry and Biochemistry Academic Press. pp 183–250.
43. Lipniunas P, Angel A-S, Erlansson K, Lindh F, Nilsson B (1992) Mass
spectrometry of high-mannose oligosaccharides after trifluoroacetolysis and
periodate oxidation. Analytical Biochemistry 200: 58–67.
44. Philip E, Thorpe PMW, Phillip P. Knowles, Michele G. Relf, Alex NF. Brown,
Graham J. Watson, David C. Blakey, David R. Newell (1988) Improved
Antitumor Effects of Immunotoxins Prepared with Deglycosylated Ricin A-
Chain and Hindered Disulfide Linkages. Cancer Res 48: 6396–6403.
45. Okano M, Satoskar AR, Nishizaki K, Abe M, Harn DA, Jr. (1999) Induction of
Th2 Responses and IgE Is Largely Due to Carbohydrates Functioning as
Adjuvants on Schistosoma mansoni Egg Antigens. J Immunol 163: 6712–6717.
46. Aoki R, Saito A, Azakami H, Kato A (2010) Effects of Various Saccharides on
the Masking of Epitope Sites and Uptake in the Gut of Cedar Allergen Cry j
12Saccharide Conjugates by a Naturally Occurring Maillard Reaction. Journal
of Agricultural and Food Chemistry 58: 7986–7990.
47. Kimura YKM, Maeda M, Okano M, Yokoyama M, Kino K (2008) Glycoform
analysis of Japanese cypress pollen allergen, Cha o 1: a comparison of the
glycoforms of cedar and cypress pollen allergens. Biosci Biotechnol Biochem 72:
485–491.
48. Seppa ¨la ¨ U, Selby D, Monsalve R, King TP, Ebner C, et al. (2009) Structural
and immunological characterization of the N-glycans from the major yellow
jacket allergen Ves v 2: The N-glycan structures are needed for the human
antibody recognition. Molecular Immunology 46: 2014–2021.
49. Plasencia MD, Isailovic D, Merenbloom SI, Mechref Y, Clemmer DE (2008)
Resolving and Assigning N-Linked Glycan Structural Isomers from Ovalbumin
by IMS-MS. Journal of the American Society for Mass Spectrometry 19:
1706–1715.
5 0 .L a u e rI a ,F o e t i s c hK a ,K o l a r i c hD b ,B a l l m e r - W e b e rB K c ,C o n t iA d ,
Altmann Fb, Vieths Sa, Scheurer Sa (2004) Hazelnut (Corylus avellana) vicilin
Cor a 11: Molecular characterization of a glycoprotein and its allergenic activity.
Biochemical Journal 383: 327–334.
51. Kolarich D, Altmann F (2000) N-Glycan Analysis by Matrix-Assisted Laser
Desorption/Ionization Mass Spectrometry of Electrophoretically Separated
Nonmammalian Proteins: Application to Peanut Allergen Ara h 1 and Olive
Pollen Allergen Ole e 1. Analytical Biochemistry 285: 64–75.
52. Malik A, Arif SAM, Ahmad S, Sunderasan E (2008) A molecular and in silico
characterization of Hev b 4, a glycosylated latex allergen. International Journal
of Biological Macromolecules 42: 185–190.
53. Commins S, Platts-Mills T (2010) Allergenicity of Carbohydrates and Their
Role in Anaphylactic Events. Current Allergy and Asthma Reports 10: 29–33.
54. Sandrine J, Denise-Anne M-V, Bernard EB (2009) Mammalian meat–induced
anaphylaxis: Clinical relevance of anti–galactose-a-1,3-galactose IgE confirmed
by means of skin tests to cetuximab. The Journal of allergy and clinical
immunology 124: 603–605.
55. Leonard RPB, Himly M, Kaar W, Wopfner N, Kolarich D, van Ree R,
Ebner C, Duus JØ, Ferreira F, Altmann F (2005) Two novel types of O-glycans
on the mugwort pollen allergen Art v 1 and their role in antibody binding. J Biol
Chem 280: 7932–7940.
56. Geijtenbeek TBH, Torensma R, van Vliet SJ, van Duijnhoven GCF, Adema GJ,
et al. (2000) Identification of DC-SIGN, a Novel Dendritic Cell-Specific ICAM-
3 Receptor that Supports Primary Immune Responses. Cell 100: 575–585.
57. Hsu SCCC, Tsai SH, Kawasaki H, Hung CH, Chu YT, Chang HW, Zhou Y,
Fu J, Plunkett B, Su SN, Vieths S, Lee RT, Lee YC, Huang SK (2010)
Functional interaction of common allergens and a C-type lectin receptor,
dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN), on human
dendritic cells. J Bio Chem 285: 7903–7910.
58. Mitsuhiro O, Kohsuke K, Teruaki T, Hisashi H, Teruhiro O, et al. (2001) Roles
of carbohydrates on Cry j 1, the major allergen of Japanese cedar pollen, in
specific T-cell responses. The Journal of allergy and clinical immunology 108:
101–108.
59. Rochman Y, Leonard WJ (2008) Thymic stromal lymphopoietin: a new cytokine
in asthma. Current Opinion in Pharmacology 8: 249–254.
60. Ray RJ, Furlonger C, Williams DE, Paige CJ (1996) Characterization of thymic
stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro.
European Journal of Immunology 26: 10–16.
61. Wang J, Xing F (2008) Human TSLP-Educated DCs. Cell Mol Immunol 5:
99–106.
62. Wang YH, Liu YJ (2009) Thymic stromal lymphopoietin, OX40-ligand, and
interleukin-25 in allergic responses. Clinical & Experimental Allergy 39:
798–806.
63. Friend SLHS, Nelson A, Foxworthe D, Williams DE, Farr A (1994) A thymic
stromal cell line supports in vitro development of surface IgM+ B cells and
produces a novel growth factor affecting B and T lineage cells. Exp Hematol 22:
321–328.
64. Tanaka J, Watanabe N, Kido M, Saga K, Akamatsu T, et al. (2009) Human
TSLP and TLR3 ligands promote differentiation of Th17 cells with a central
memory phenotype under Th2-polarizing conditions. Clinical & Experimental
Allergy 39: 89–100.
65. Miyata M, Nakamura Y, Shimokawa N, Ohnuma Y, Katoh R, et al. (2009)
Thymic stromal lymphopoietin is a critical mediator of IL-13-driven allergic
inflammation. European Journal of Immunology 39: 3078–3083.
66. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, et al. (2009)
House dust mite allergen induces asthma via Toll-like receptor 4 triggering of
airway structural cells. Nat Med 15: 410–416.
67. Kashyap M, Rochman Y, Spolski R, Samsel L, Leonard WJ (2011) Thymic
Stromal Lymphopoietin Is Produced by Dendritic Cells. The Journal of
Immunology.
68. Emara M, Royer PJ, Abbas Z, Sewell HF, Mohamed GG, et al. (2011)
Recognition of the major cat allergen Fel d 1 through the cysteine-rich domain
of the mannose receptor determines its allergenicity. J Biol Chem 286:
13033–13040.
69. Emara M, Royer PJ, Mahdavi J, Shakib F, Ghaemmaghami AM (2011)
Retagging identifies dendritic cell-specific ICAM3-grabbing non-integrin (DC-
SIGN) as a novel receptor for a major allergen from house dust mite. J Biol
Chem The Journal of Biological Chemistry 287: 5756–5763.
70. Linhart B, Valenta R (2011) Mechanisms underlying allergy vaccination with
recombinant hypoallergenic allergen derivatives. Vaccine, Available: http://dx.
doi.org/10.1016/j.vaccine.2011.11.011. www.sciencedirect.com website. Ac-
cessed 2012 March 1.
71. Jutel M, Akdis CA (2011) Immunological mechanisms of allergen-specific
immunotherapy. Allergy 66: 725–732.
Allergen Glycosylation and Allergenicity
PLoS ONE | www.plosone.org 11 March 2012 | Volume 7 | Issue 3 | e33929